JournalsHub
.online
Find My Journal
JL

Jacob Lalezari

Attodyne (Canada) CA

ORCID 0000-0002-2744-4918
194
Publications
13,789
Citations
57
H-Index
112
i10-Index
1.33
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

192 total

Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIV.

A. G. P. dos Santos, Manal Abunimeh, Beatriz Mothe, J. Routy, Jacob P. Lalezari - Contemporary Clinical Trials, 2025
Cited by 0 Semantic Scholar

Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled Trial

J. Gathe, Edwin Dejesus, M. Ramgopal, Charlotte-Paige Rolle, Otto O Yang - Journal of Acquired Immune Deficiency Syndromes, 2025
Cited by 3 Semantic Scholar

Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study

M. Ramgopal, Jacob P. Lalezari, Ana Gabriela Pires dos Santos, Preethi Krishnan, Tanaya R. Vaidya - Nature Medicine, 2025
Cited by 3 Semantic Scholar

365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment OA

Alftan Dyson, Judith A Aberg, Jean-Michel Molina, I. Cassetti, Michael J Kozal - Open Forum Infectious Diseases, 2023
Cited by 1 Semantic Scholar

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson, Eric Lawitz, Stuart C. Gordon et al. - New England Journal of Medicine, 2014
Cited by 1,302 OpenAlex

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV PDF

Péter Ferenci, David Bernstein, Jacob Lalezari, Daniel E. Cohen, Yan Luo et al. - New England Journal of Medicine, 2014
Cited by 692 OpenAlex

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection PDF

Roy M. Gulick, Jacob Lalezari, James Goodrich, Nathan Clumeck, Edwin DeJesus et al. - New England Journal of Medicine, 2008
Cited by 737 OpenAlex

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America PDF

Jacob Lalezari, Keith Henry, Mary O’Hearn, Joan Montaner, Peter J. Piliero et al. - New England Journal of Medicine, 2003
Cited by 911 OpenAlex

Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. OA

Oren J. Cohen, G. Pantaleo, Mark Holodniy, Cecil H. Fox, J. M. Orenstein - Journal of Infectious Diseases, 1996
Cited by 25 Semantic Scholar

Research Topics

HIV/AIDS drug development and treatment (81) HIV Research and Treatment (71) Hepatitis C virus research (67) Cytomegalovirus and herpesvirus research (42) HIV/AIDS Research and Interventions (34)

Affiliations

Sutter Health
US 1996 - 1996
Goethe University Frankfurt
DE 2009 - 2009
Roche (Switzerland)
CH 2005 - 2005
San Francisco General Hospital
US 1994 - 1994
Research Triangle Park Foundation
US 1995 - 1995

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now